2026 annual financial data
PharmaCyte Biotech, Inc. 2026 Operating margin
PharmaCyte Biotech, Inc. 2026 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -5,304,286 USD and net income was -19,424,654 USD.
Operating cash flow was -5,152,914 USD.
Get free PharmaCyte Biotech, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -5,304,286 USD
- Net income
- -19,424,654 USD
- Operating cash flow
- -5,152,914 USD